辉瑞

Pfizer admits jobs and R&D budget will fall if AstraZeneca move succeeds
辉瑞承认收购阿斯利康后将裁员


辉瑞掌门人在接受英国议员质询时拒绝排除在英国裁员的可能性

Pfizer will cut its research budget and global headcount if it succeeds in taking over AstraZeneca, the US drugs maker acknowledged yesterday, amid mounting expectations that it will raise the informal £63bn offer for its UK rival.

美国制药公司辉瑞(Pfizer)昨日承认,如果成功收购其英国竞争对手阿斯利康(AstraZeneca),就会削减研发预算并在manbetx app苹果 裁员。目前各方日益预期辉瑞将提高其630亿英镑收购阿斯利康的非正式报价。